Pagoto Sherry, Xu Ran, Bannor Richard, Idiong Christie, Goetz Jared, Fernandes Denise
Department of Allied Health Sciences, University of Connecticut, Storrs, CT, United States.
JMIR Res Protoc. 2024 Dec 19;13:e65323. doi: 10.2196/65323.
Remotely delivered lifestyle interventions have emerged to increase the reach and accessibility of traditional interventions that involve numerous in-person visits. Remote interventions can be delivered synchronously via videoconference software or phone or asynchronously via online platforms. Asynchronously delivered interventions are convenient and flexible in that they allow people to participate at any time and as such, they may be more sustainable. Evidence for asynchronous interventions is needed given their potential for convenience and sustainability, which may have implications for weight loss maintenance.
This is a randomized noninferiority trial comparing 2 remotely delivered lifestyle interventions: one that is delivered synchronously via videoconference meetings and one that is delivered asynchronously through private Facebook (Meta) groups. We hypothesize that the percent weight loss difference between conditions at 6 and 12 months will be less than 2% and that the asynchronous condition will cost less to deliver per pound lost. We also hypothesize that engagement will be higher in the asynchronous condition at 12, 18, and 24 months and that the asynchronous condition will have greater weight loss at 24 months.
We will randomize 328 participants with overweight or obesity to a remotely delivered lifestyle intervention that is delivered either synchronously or asynchronously. Delivery of the synchronous lifestyle intervention will be via videoconference group sessions, whereas the delivery of the asynchronous lifestyle intervention will be via private Facebook groups. The lifestyle intervention in both conditions is based on the Diabetes Prevention Program. The intervention goals are to lose 5%-10% of baseline weight and to work toward 300 minutes per week of moderate intensity physical activity. The core intervention will last for 12 months and be led by counselors in each group. This will be followed by a 12-month maintenance phase to be led by participant volunteers from each group. Participant engagement and weight loss maintenance will be assessed during this phase. The primary outcome is mean percent weight loss at 6 and 12 months. The noninferiority margin for differences in weight loss between conditions is 2% at both 6 and 12 months. We will model percent weight loss at 6 and 12 months using general linear regression models with the intent-to-treat sample. Secondary outcomes include engagement, collective efficacy, cost, and weight loss at 18 and 24 months.
The funding period began on August 17, 2023, and the study was approved by the University of Connecticut Institutional Review Board on August 17, 2023. Participant recruitment will begin December 2024 and the intervention will begin February 2024.
If hypotheses are confirmed, this work will provide evidence that asynchronously delivered remote interventions are as efficacious as synchronously delivered ones and more sustainable such that people will engage in them longer and retain more weight loss for less cost.
ClinicalTrials.gov NCT06393725; https://tinyurl.com/4kzzwkc9.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/65323.
远程提供的生活方式干预措施已出现,以扩大涉及多次面对面就诊的传统干预措施的覆盖范围和可及性。远程干预可以通过视频会议软件或电话同步进行,也可以通过在线平台异步进行。异步提供的干预措施方便灵活,因为它们允许人们在任何时间参与,因此可能更具可持续性。鉴于异步干预在便利性和可持续性方面的潜力,这可能对维持体重减轻有影响,因此需要其相关证据。
这是一项随机非劣效性试验,比较两种远程提供的生活方式干预措施:一种通过视频会议同步进行,另一种通过私人Facebook(Meta)群组异步进行。我们假设,6个月和12个月时各干预组之间的体重减轻百分比差异将小于2%,并且异步干预组每减轻一磅体重的成本更低。我们还假设,在12个月、18个月和24个月时,异步干预组的参与度会更高,并且在24个月时,异步干预组的体重减轻幅度会更大。
我们将把328名超重或肥胖参与者随机分配到通过同步或异步方式提供的远程生活方式干预组。同步生活方式干预将通过视频会议小组会议进行,而异步生活方式干预将通过私人Facebook群组进行。两种干预条件下的生活方式干预均基于糖尿病预防计划。干预目标是减轻基线体重的5%-10%,并努力达到每周300分钟的中等强度体育活动。核心干预将持续12个月,由每组的辅导员领导。接下来是为期12个月的维持阶段,由每组的参与者志愿者领导。在此阶段将评估参与者的参与度和体重减轻维持情况。主要结局是6个月和12个月时的平均体重减轻百分比。两种干预条件下体重减轻差异的非劣效性界值在6个月和12个月时均为2%。我们将使用意向性治疗样本,通过一般线性回归模型对6个月和12个月时的体重减轻百分比进行建模。次要结局包括18个月和24个月时的参与度、集体效能、成本和体重减轻情况。
资助期于2023年8月17日开始,该研究于2023年8月17日获得康涅狄格大学机构审查委员会的批准。参与者招募将于2024年12月开始,干预将于2024年2月开始。
如果假设得到证实,这项工作将提供证据表明,异步提供的远程干预与同步提供的干预同样有效,且更具可持续性,即人们会更长时间地参与其中,以更低的成本保持更多的体重减轻。
ClinicalTrials.gov NCT06393725;https://tinyurl.com/4kzzwkc9。
国际注册报告识别码(IRRID):PRR1-10.2196/65323。